Skip to main content
Erschienen in: Pediatric Nephrology 12/2006

01.12.2006 | Brief Report

C1q nephropathy in association with Gitelman syndrome: a case report

verfasst von: Coral Hanevold, Ayesa Mian, Rory Dalton

Erschienen in: Pediatric Nephrology | Ausgabe 12/2006

Einloggen, um Zugang zu erhalten

Abstract

There have been rare reports of glomerulopathies developing in patients with Bartter syndrome (BS) and its milder variant, Gitelman syndrome (GS). We present the first case of C1q nephropathy (C1qN) in an African American child with GS. This child was diagnosed with GS at 9 years of age and subsequently developed nephrotic range proteinuria 3 years later. Renal biopsy revealed mesangial hypercellularity and focal segmental glomerulosclerosis (FSGS). The segmental lesions were generally located at the vascular pole. Dominant C1q (2+) staining along with IgG (1–2+) was demonstrated in the mesangium, which correlated with scattered electron dense mesangial deposits demonstrated by electron microscopy. Treatment with an angiotensin-converting enzyme inhibitor led to an improvement in proteinuria to near-normal values (urine protein/creatinine ratio down to 0.5), but the creatinine clearance declined to approximately 58 ml/min/1.73 m2. This case highlights the possible association between the milder hypokalemic tubulopathy, GS, and glomerular disease, including C1qN. Prompt evaluation of proteinuria with renal biopsy in these patients is recommended to detect significant glomerular pathology. Further research is needed to define risk factors for this complication.
Literatur
1.
Zurück zum Zitat Su IH, Frank R, Gauthier BG, Valderrama E, Simon DB, Lifton RP, Trachtman H (2000) Bartter syndrome and focal segmental glomerulosclerosis: a possible link between two diseases. Pediatr Nephrol 14:970–972CrossRef Su IH, Frank R, Gauthier BG, Valderrama E, Simon DB, Lifton RP, Trachtman H (2000) Bartter syndrome and focal segmental glomerulosclerosis: a possible link between two diseases. Pediatr Nephrol 14:970–972CrossRef
2.
Zurück zum Zitat Calò LA, Marchini F, Davis PA, Rigotti P, Pagnin E, Semplicini A (2003) Kidney transplant in Gitelman’s syndrome. Report of the first case. J Nephrol 16:144–147PubMed Calò LA, Marchini F, Davis PA, Rigotti P, Pagnin E, Semplicini A (2003) Kidney transplant in Gitelman’s syndrome. Report of the first case. J Nephrol 16:144–147PubMed
3.
Zurück zum Zitat Bonfante L, Davis PA, Spinello M, Antonello A, D’Angelo AD, Semplicini A, Calo L (2001) Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman’s syndrome. Am J Kidney Dis 38:165–168CrossRef Bonfante L, Davis PA, Spinello M, Antonello A, D’Angelo AD, Semplicini A, Calo L (2001) Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman’s syndrome. Am J Kidney Dis 38:165–168CrossRef
4.
Zurück zum Zitat Bulucu F, Vural A, Yenicesu M, Caglar K (1998) Association of Gitelman’s syndrome and focal glomerulosclerosis. Nephron 79:244CrossRef Bulucu F, Vural A, Yenicesu M, Caglar K (1998) Association of Gitelman’s syndrome and focal glomerulosclerosis. Nephron 79:244CrossRef
5.
Zurück zum Zitat Blethen SL, Van Wyck JJ, Lorentz WB, Jennette JC (1985) Reversal of Bartter’s syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis. Am J Med Sci 289:31–36CrossRef Blethen SL, Van Wyck JJ, Lorentz WB, Jennette JC (1985) Reversal of Bartter’s syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis. Am J Med Sci 289:31–36CrossRef
6.
Zurück zum Zitat Sardani Y, Qin K, Haas M, Aronson AJ, Rosenfield RL (2003) Bartter syndrome complicated by immune complex nephropathy. Case report and literature review. Pediatr Nephrol 18:913–918CrossRef Sardani Y, Qin K, Haas M, Aronson AJ, Rosenfield RL (2003) Bartter syndrome complicated by immune complex nephropathy. Case report and literature review. Pediatr Nephrol 18:913–918CrossRef
7.
Zurück zum Zitat Cortesi C, Foglia PEG, Bettinelli A, Bianchetti MG (2003) Prevention of cardiac arrhythmias in pediatric patients with normotensive-hypokalemic tubulopathy. Current attitude among European pediatricians. Pediatr Nephrol 18:729–730CrossRef Cortesi C, Foglia PEG, Bettinelli A, Bianchetti MG (2003) Prevention of cardiac arrhythmias in pediatric patients with normotensive-hypokalemic tubulopathy. Current attitude among European pediatricians. Pediatr Nephrol 18:729–730CrossRef
8.
Zurück zum Zitat Pachulski RT, Lopez F, Sharaf R (2005) Gitelman’s not-so-benign syndrome. New Engl J Med 353:850–851CrossRef Pachulski RT, Lopez F, Sharaf R (2005) Gitelman’s not-so-benign syndrome. New Engl J Med 353:850–851CrossRef
9.
Zurück zum Zitat Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB (2001) Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59:710–717CrossRef Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB (2001) Gitelman’s syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59:710–717CrossRef
10.
Zurück zum Zitat Doi T, Kanatsu K, Suehiro F, Nagai H, Yoshida H, Hamashima Y (1987) Clinicopathological study of patients with mesangial isolated C3d deposition in various glomerular diseases. Nephron 46:188–193CrossRef Doi T, Kanatsu K, Suehiro F, Nagai H, Yoshida H, Hamashima Y (1987) Clinicopathological study of patients with mesangial isolated C3d deposition in various glomerular diseases. Nephron 46:188–193CrossRef
11.
Zurück zum Zitat Cannon PJ, Leeming JM, Sommers SC, Winters RW, Laragh JH (1968) Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter’s syndrome): a re-evaluation of the pathophysiology. Medicine (Baltimore) 47:107–131CrossRef Cannon PJ, Leeming JM, Sommers SC, Winters RW, Laragh JH (1968) Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter’s syndrome): a re-evaluation of the pathophysiology. Medicine (Baltimore) 47:107–131CrossRef
12.
Zurück zum Zitat Rudin A (1988) Bartter’s syndrome. A review of 28 patients followed for 10 years. Acta Med Scand 224:165–171CrossRef Rudin A (1988) Bartter’s syndrome. A review of 28 patients followed for 10 years. Acta Med Scand 224:165–171CrossRef
13.
Zurück zum Zitat Fogo AB (2001) Progression and potential regression of glomerulosclerosis. Kidney Int 59:804–819CrossRef Fogo AB (2001) Progression and potential regression of glomerulosclerosis. Kidney Int 59:804–819CrossRef
14.
Zurück zum Zitat Wolf G, Butzmann U, Wenzel UO (2003) The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 93:3–13CrossRef Wolf G, Butzmann U, Wenzel UO (2003) The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 93:3–13CrossRef
15.
Zurück zum Zitat Seikaly MG, Arant BS Jr, Seney FD Jr (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352–1357CrossRef Seikaly MG, Arant BS Jr, Seney FD Jr (1990) Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86:1352–1357CrossRef
16.
Zurück zum Zitat Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103–110CrossRef Jennette JC, Hipp CG (1985) C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 6:103–110CrossRef
17.
Zurück zum Zitat Jennette JC, Falk RJ (2001) C1q nephrology. In: Massry SG, Glassock RJ (eds) Massry and Glassock’s textbook of nephrology, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, Pennsylvania, pp 730–733 Jennette JC, Falk RJ (2001) C1q nephrology. In: Massry SG, Glassock RJ (eds) Massry and Glassock’s textbook of nephrology, 4th edn. Lippincott, Williams & Wilkins, Philadelphia, Pennsylvania, pp 730–733
18.
Zurück zum Zitat Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D’Agati VD (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232–1240CrossRef Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D’Agati VD (2003) C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 64:1232–1240CrossRef
19.
Zurück zum Zitat Shappell SB, Myrthil G, Fogo A (1997) An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis 29:966–970CrossRef Shappell SB, Myrthil G, Fogo A (1997) An adolescent with relapsing nephrotic syndrome: minimal-change disease versus focal-segmental glomerulosclerosis versus C1q nephropathy. Am J Kidney Dis 29:966–970CrossRef
20.
Zurück zum Zitat Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 18:459–465CrossRef Iskandar SS, Browning MC, Lorentz WB (1991) C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis 18:459–465CrossRef
21.
Zurück zum Zitat Lau KK, Gaber LW, Santo NM, Wyatt RJ (2005) C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 20:744–749CrossRef Lau KK, Gaber LW, Santo NM, Wyatt RJ (2005) C1q nephropathy: features at presentation and outcome. Pediatr Nephrol 20:744–749CrossRef
22.
Zurück zum Zitat Kersnik Levart T, Kenda RB, Cavic MA, Ferlung D, Hvala A, Vizjak A (2005) C1q nephropathy in children. Pediatr Nephrol 20:1756–1761CrossRef Kersnik Levart T, Kenda RB, Cavic MA, Ferlung D, Hvala A, Vizjak A (2005) C1q nephropathy in children. Pediatr Nephrol 20:1756–1761CrossRef
23.
Zurück zum Zitat Guay-Woodford LM (1998) Bartter syndrome: unraveling the pathophysiologic enigma. Am J Med 105:151–161CrossRef Guay-Woodford LM (1998) Bartter syndrome: unraveling the pathophysiologic enigma. Am J Med 105:151–161CrossRef
24.
Zurück zum Zitat Schurman SJ, Perlman SA, Sutphen R, Campos A, Garin EH, Cruz DN, Shoemaker LR (2001) Genotype/phenotype observations in African Americans with Bartter syndrome. J Pediatr 139:105–110CrossRef Schurman SJ, Perlman SA, Sutphen R, Campos A, Garin EH, Cruz DN, Shoemaker LR (2001) Genotype/phenotype observations in African Americans with Bartter syndrome. J Pediatr 139:105–110CrossRef
25.
Zurück zum Zitat Suthanthiran M, Khanna A, Cukran D, Adhikarla R, Sharma VK, Singh T, August P (1998) Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients. Kidney Int 53:639–644CrossRef Suthanthiran M, Khanna A, Cukran D, Adhikarla R, Sharma VK, Singh T, August P (1998) Transforming growth factor-β1 hyperexpression in African American end-stage renal disease patients. Kidney Int 53:639–644CrossRef
26.
Zurück zum Zitat Zelikovic I (2003) Hypokalaemic salt-losing tubulopathies: an evolving story. Nephrol Dial Transplant 18:1696–1700CrossRef Zelikovic I (2003) Hypokalaemic salt-losing tubulopathies: an evolving story. Nephrol Dial Transplant 18:1696–1700CrossRef
27.
Zurück zum Zitat Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N, Nakhoul F (2003) A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 63:24–32CrossRef Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N, Nakhoul F (2003) A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 63:24–32CrossRef
28.
Zurück zum Zitat Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW (2000) Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 48:754–758CrossRef Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW (2000) Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 48:754–758CrossRef
Metadaten
Titel
C1q nephropathy in association with Gitelman syndrome: a case report
verfasst von
Coral Hanevold
Ayesa Mian
Rory Dalton
Publikationsdatum
01.12.2006
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 12/2006
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0261-9

Weitere Artikel der Ausgabe 12/2006

Pediatric Nephrology 12/2006 Zur Ausgabe

Referees for 2006

Acknowledgements

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.